These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12678333)

  • 1. Defining relapse of ulcerative colitis using a symptom-based activity index.
    Jowett SL; Seal CJ; Phillips E; Gregory W; Barton JR; Welfare MR
    Scand J Gastroenterol; 2003 Feb; 38(2):164-71. PubMed ID: 12678333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The patient simple clinical colitis activity index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: a comparison of the P-SCCAI with clinician-based SCCAI and biological markers.
    Bennebroek Evertsz' F; Nieuwkerk PT; Stokkers PC; Ponsioen CY; Bockting CL; Sanderman R; Sprangers MA
    J Crohns Colitis; 2013 Dec; 7(11):890-900. PubMed ID: 23269224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Performance of the Simple Clinical Colitis Activity Index Self-Administered Online at Home by Patients With Ulcerative Colitis: CRONICA-UC Study.
    Marín-Jiménez I; Nos P; Domènech E; Riestra S; Gisbert JP; Calvet X; Cortés X; Iglesias E; Huguet JM; Taxonera C; Fernández R; Carpio D; Gutiérrez A; Guardiola J; Laria LC; Sicilia B; Bujanda L; Cea-Calvo L; Romero C; Rincón Ó; Juliá B; Panés J
    Am J Gastroenterol; 2016 Feb; 111(2):261-8. PubMed ID: 26753886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo score and the simple clinical colitis activity index.
    Bewtra M; Brensinger CM; Tomov VT; Hoang TB; Sokach CE; Siegel CA; Lewis JD
    Inflamm Bowel Dis; 2014 Jun; 20(6):1070-8. PubMed ID: 24810138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between disease activity and quality of life in ulcerative colitis: Results from the CRONICA-UC study.
    Panés J; Domènech E; Aguas Peris M; Nos P; Riestra S; Juliá de Páramo B; Cea-Calvo L; Romero C; Marín-Jiménez I
    J Gastroenterol Hepatol; 2017 Nov; 32(11):1818-1824. PubMed ID: 28370253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does colonoscopy cause increased ulcerative colitis symptoms?
    Menees S; Higgins P; Korsnes S; Elta G
    Inflamm Bowel Dis; 2007 Jan; 13(1):12-8. PubMed ID: 17206634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis.
    Carlsen K; Riis LB; Elsberg H; Maagaard L; Thorkilgaard T; Sørbye SW; Jakobsen C; Wewer V; Florholmen J; Goll R; Munkholm P
    Scand J Gastroenterol; 2018; 53(7):825-830. PubMed ID: 29968483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum human trefoil factor 3 is a biomarker for mucosal healing in ulcerative colitis patients with minimal disease activity.
    Srivastava S; Kedia S; Kumar S; Pratap Mouli V; Dhingra R; Sachdev V; Tiwari V; Kurrey L; Pradhan R; Ahuja V
    J Crohns Colitis; 2015 Jul; 9(7):575-9. PubMed ID: 25964429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis.
    Mohammed Vashist N; Samaan M; Mosli MH; Parker CE; MacDonald JK; Nelson SA; Zou GY; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD011450. PubMed ID: 29338066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consecutive Measurements by Faecal Immunochemical Test in Quiescent Ulcerative Colitis Patients Can Detect Clinical Relapse.
    Hiraoka S; Kato J; Nakarai A; Takashima S; Inokuchi T; Takei D; Sugihara Y; Takahara M; Harada K; Okada H
    J Crohns Colitis; 2016 Jun; 10(6):687-94. PubMed ID: 26802083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.
    Turner D; Otley AR; Mack D; Hyams J; de Bruijne J; Uusoue K; Walters TD; Zachos M; Mamula P; Beaton DE; Steinhart AH; Griffiths AM
    Gastroenterology; 2007 Aug; 133(2):423-32. PubMed ID: 17681163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis-a Prospective Analysis.
    Walsh A; Kormilitzin A; Hinds C; Sexton V; Brain O; Keshav S; Uhlig H; Geddes J; Goodwin G; Peters M; Collins G; Travis S
    J Crohns Colitis; 2019 Mar; 13(4):424-430. PubMed ID: 30445625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ immune response as a potential biomarker of patient reported inflammatory bowel disease (IBD) activity.
    Brandhorst G; Weigand S; Eberle C; Raddatz D; Karaus M; Oellerich M; Walson PD
    Clin Chim Acta; 2013 Jun; 421():31-3. PubMed ID: 23485644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment.
    Theede K; Kiszka-Kanowitz M; Nielsen AM; Nordgaard-Lassen I
    Scand J Gastroenterol; 2014 Apr; 49(4):418-23. PubMed ID: 24495103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profermin is efficacious in patients with active ulcerative colitis--a randomized controlled trial.
    Krag A; Munkholm P; Israelsen H; von Ryberg B; Andersen KK; Bendtsen F
    Inflamm Bowel Dis; 2013 Nov; 19(12):2584-92. PubMed ID: 24108114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation of the inflammatory bowel disease questionnaire in Swedish patients with ulcerative colitis.
    Hjortswang H; Järnerot G; Curman B; Sandberg-Gertzén H; Tysk C; Blomberg B; Almer S; Ström M
    Scand J Gastroenterol; 2001 Jan; 36(1):77-85. PubMed ID: 11218243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Subramanian S; Asher R; Weston W; Rimmer M; McConville A; Malin A; Jackson R; Collins P; Probert C; Dibb M; Rhodes JM
    Inflamm Bowel Dis; 2016 Aug; 22(8):1902-7. PubMed ID: 27243590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study.
    Jauregui-Amezaga A; López-Cerón M; Aceituno M; Jimeno M; Rodríguez de Miguel C; Pinó-Donnay S; Zabalza M; Sans M; Ricart E; Ordás I; González-Suárez B; Cuatrecasas M; Llach J; Panés J; Pellise M
    Inflamm Bowel Dis; 2014 Jul; 20(7):1187-93. PubMed ID: 24874457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between Treg quantification assays in inflammatory bowel disease patients.
    Brandhorst G; Petrova DT; Weigand S; Eberle C; von Ahsen N; Schmitz J; Schultze FC; Raddatz D; Karaus M; Oellerich M; Walson PD
    World J Gastroenterol; 2015 Mar; 21(11):3325-9. PubMed ID: 25805940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.